Log in

NASDAQ:MGNXMacroGenics Earnings Date, Estimates & History

-0.07 (-0.26 %)
(As of 08/13/2020 04:00 PM ET)
Today's Range
Now: $26.67
50-Day Range
MA: $27.79
52-Week Range
Now: $26.67
Volume411,100 shs
Average Volume1.63 million shs
Market Capitalization$1.44 billion
P/E RatioN/A
Dividend YieldN/A


MacroGenics (NASDAQ:MGNX) Earnings Information

MacroGenics last posted its quarterly earnings data on July 30th, 2020. The biopharmaceutical company reported ($0.94) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.92) by $0.02. The business earned $20.26 million during the quarter, compared to analysts' expectations of $14.19 million. MacroGenics has generated ($3.16) earnings per share over the last year. MacroGenics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 4th, 2020 based off prior year's report dates.

MacroGenics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MacroGenics (NASDAQ:MGNX) Earnings Estimates

2020 EPS Consensus Estimate: ($3.03)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20202($1.17)($0.95)($1.06)
Q2 20202($1.05)($0.55)($0.80)
Q3 20202($0.94)($0.51)($0.73)
Q4 20202($0.53)($0.36)($0.45)

MacroGenics (NASDAQ MGNX) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
7/30/20206/30/2020($0.92)($0.94)($0.94)$14.19 million$20.26 millionTranscript
5/5/20203/31/2020($1.01)($0.91)($0.91)$7.43 million$13.68 millionTranscript
2/25/2020Q4 2019($0.71)($0.61)($0.62)$10.74 million$25.19 millionTranscript
11/6/2019Q3($0.94)($0.91)($0.91)$23.33 million$18.74 millionTranscript
7/31/2019Q2($0.96)($0.65)($0.65)$17.58 million$10.59 millionN/A
5/1/20193/31/2019($0.95)($0.99)($0.99)$11.46 million$9.66 millionTranscript
2/26/2019Q4 2018($0.98)($1.06)($1.06)$14.45 million$15.79 millionN/A
11/7/20189/30/2018($1.29)($0.81)($0.81)$6.18 million$20.80 millionN/A
8/7/2018Q2 2018($1.20)($1.03)($1.03)$4.41 million$18.83 millionN/A
5/7/2018Q1 2018($1.08)($1.34)($1.34)$7.46 million$4.70 millionN/A
2/27/2018Q4 2017$2.58$2.80$2.80$152.59 million$152.36 millionN/A
11/8/2017Q3 2017($1.09)($1.28)($1.28)$5.50 million$1.70 millionN/A
8/2/2017Q2 2017($1.05)($1.14)($1.14)$15.82 million$1.70 millionListen
5/3/2017Q1 2017($0.99)($1.08)($1.08)$5.88 million$2.06 millionListen
2/28/2017Q416($0.86)($1.00)($1.00)$10.65 million$5.00 millionListen
11/2/2016Q316($0.80)($0.97)($0.97)$12.45 million$3.30 millionN/A
8/3/2016Q216($0.02)$1.12$1.12$27.22 million$80.67 millionN/A
5/4/2016Q1($0.67)($0.88)($0.88)$10.95 million$2.85 millionN/A
2/29/2016Q4 2015($0.56)($0.89)($0.89)$12.36 million$8.18 millionN/A
11/4/2015Q3 2015($0.21)($0.46)($0.46)$22.95 million$14.68 millionN/A
8/5/2015Q2($0.44)($0.71)($0.71)$13.88 million$6.72 millionN/A
5/6/2015Q1 2015$0.87($0.58)($2.58)$58.29 million$71.28 millionN/A
3/3/2015Q4 2014($0.36)($0.69)($0.69)$12.41 million$5.48 millionN/A
11/11/2014Q3 2014($0.42)($0.14)($0.14)$9.43 million$18.38 millionListen
8/5/2014Q2 2014($0.29)($0.44)($0.44)$11.22 million$9.22 millionN/A
5/6/2014Q1 2014($0.09)($0.12)($0.12)$18.00 million$14.72 millionN/A
11/12/2013Q3 2013$0.15$0.01$0.01$19.67 million$20.23 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 8/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.